Mammalian target of rapamycin as a therapeutic target in oncology

Author： Abraham Robert T   Eng Christina H  

Publisher： Informa Healthcare

ISSN： 1472-8222

Source： Expert Opinion on Therapeutic Targets, Vol.12, Iss.2, 2008-02, pp. : 209-222

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Inhibitors of the mammalian target of rapamycin

By Dancey Janet E  

Expert Opinion on Investigational Drugs, Vol. 14, Iss. 3, 2005-03 ,pp. : 313-328

Informa Healthcare

Access to resources Recommend Favorite

Novel therapeutic strategy for breast cancer: mammalian target of rapamycin inhibition

By Yip Adrian Yun-San   Ong Eleanor Yuen-Yuen   Chow Louis Wing-Cheong  

Expert Opinion on Drug Discovery, Vol. 4, Iss. 4, 2009-04 ,pp. : 457-466

Informa Healthcare

Access to resources Recommend Favorite

Therapeutic potential of target of rapamycin inhibitors

By Easton John B   Houghton Peter J  

Expert Opinion on Therapeutic Targets, Vol. 8, Iss. 6, 2004-12 ,pp. : 551-564

Informa Healthcare

Access to resources Recommend Favorite

Next generation of mammalian target of rapamycin inhibitors for the treatment of cancer

By Nelson Valerie   Altman Jessica K   Platanias Leonidas C  

Expert Opinion on Investigational Drugs, Vol. 22, Iss. 6, 2013-09 ,pp. : 715-722

Informa Healthcare

Access to resources Recommend Favorite

Current and future directions in mammalian target of rapamycin inhibitors development

By Fasolo Angelica   Sessa Cristiana  

Expert Opinion on Investigational Drugs, Vol. 20, Iss. 3, 2011-03 ,pp. : 381-394

Informa Healthcare

Access to resources Recommend Favorite